Specifically, TGF-β was significantly elevated in the low-RCF BC compared to the high-RCF BC (p < 0.05) and in the low-RCF UL compared to both the high-RCF BC (p < 0.01) and the high-RCF UL (p < 0.01). This evidence concerns the gene TGFB1 and breast cancer.